RP-6306immunotherapycastration-resistant prostate cancer (CRPC)CRPCsyngeneic mouse models
…nes, including CCL5 and CXCL10. The selective PKMYT1 inhibitor, RP-6306, enhanced the efficacy of ICB in the presence of CD8 + T cells.…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: RP-6306 ×
RP-6306
This drug is selected. Its supporting articles are shown below.